Foldamer-templated catalysis of macrocycle formation
- PMID: 31857487
- PMCID: PMC7956107
- DOI: 10.1126/science.aax7344
Foldamer-templated catalysis of macrocycle formation
Abstract
Macrocycles, compounds containing a ring of 12 or more atoms, find use in human medicine, fragrances, and biological ion sensing. The efficient preparation of macrocycles is a fundamental challenge in synthetic organic chemistry because the high entropic cost of large-ring closure allows undesired intermolecular reactions to compete. Here, we present a bioinspired strategy for macrocycle formation through carbon-carbon bond formation. The process relies on a catalytic oligomer containing α- and β-amino acid residues to template the ring-closing process. The α/β-peptide foldamer adopts a helical conformation that displays a catalytic primary amine-secondary amine diad in a specific three-dimensional arrangement. This catalyst promotes aldol reactions that form rings containing 14 to 22 atoms. Utility is demonstrated in the synthesis of the natural product robustol.
Copyright © 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.
Figures



Comment in
-
Peptidic catalysts for macrocycle synthesis.Science. 2019 Dec 20;366(6472):1454. doi: 10.1126/science.aaz9325. Science. 2019. PMID: 31857472 No abstract available.
References
-
- Campos KR, Coleman PJ, Alvarez JC, Dreher SD, Garbaccio RM, Terrett NK, Tillyer RD, Truppo MD, Parmee ER, The importance of synthetic chemistry in the pharmaceutical industry. Science 363, 6424 (2019). - PubMed
-
- Newman DJ, Cragg GM, Macrocycles in Drug Discovery 1–499 (2014).
-
- Iyoda M, Yamakawa J, Rahman MJ, Conjugated macrocycles: Concepts and applications. Angew. Chem. Int. Ed 50, 10522–10553 (2011). - PubMed
-
- Rosenquist A, Samuelsson B, Johansson P-O, Cummings MD, Lenz O, Raboisson P, Simmen K, Vendeville S, de Kock H, Nilsson M, Horvath A, Kalmeijer R, de las Rosa G, Beumont-Mauviel M, Discovery and development of Simeprevir (TMC435), aHCVNS3/4A protease inhibitor. J. Med. Chem 57, 1673–1693 (2014). - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources